(Q44018632)

29 November 2017

title

Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser (English)

1 reference

29 November 2017

1 reference

1 reference

G Milano

1

1 reference

29 November 2017

V Troger

2

1 reference

29 November 2017

A Courdi

3

1 reference

29 November 2017

X Fontana

4

1 reference

29 November 2017

P Chauvel

5

1 reference

29 November 2017

J L Lagrange

6

1 reference

29 November 2017

publication date

1 January 1990

1 reference

Cancer Chemotherapy and Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

27

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

55-59

1 reference

A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors

29 November 2017

cites work

1 reference

12 December 2020

Renal tubular function in patients treated with high-dose cisplatin

1 reference

12 December 2020

Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diamminedichloroplatinum administration in patients with uterine cervical cancer

1 reference

12 December 2020

Clinical pharmacokinetics of commonly used anticancer drugs.

1 reference

12 December 2020

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity

1 reference

12 December 2020

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin

1 reference

12 December 2020

The long-term effect of cisplatin on renal function

1 reference

12 December 2020

Interactions between clinically effective antitumor drugs and radiation in experimental systems

1 reference

12 December 2020

Renal toxicity with cumulative doses of cis-diamminedichloroplatinum-II in pediatric patients with osteosarcoma. Effect on creatinine clearance and methotrexate excretion

1 reference

12 December 2020

Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients

1 reference

12 December 2020

The pharmacokinetics of cisplatin in experimental regional chemotherapy

1 reference

12 December 2020

Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data

1 reference

12 December 2020

Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity

1 reference

12 December 2020

Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC).

1 reference

12 December 2020

Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts

1 reference

12 December 2020

Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689277

1 reference

29 November 2017

1 reference